DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...
More than a decade after the first Neanderthal genome was sequenced, scientists are still working to understand how ...
Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...
A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback